News
Biocon Biologics secures multiple market access agreements in US for Yesintek
"Yesintek represents an important milestone for Biocon Biologics, as this is the first product we have launched in the United States as a fully integrated biosimilars company," Biocon Biologics CEO & Managing Director Shreehas Tambe said.
Avammune Therapeutics Raises INR 100 Crore in Series A
"This funding validates our extensive preclinical datasets and empowers us to accelerate the development of our lead program into the clinic for addressing critical unmet needs in oncology," said Papaiah, co-founder of Avammune.
ABLE with the Indian Life science delegation to Paris
Choose Paris Region is Paris Region's international attractiveness agency, which promotes the region's influence on the international stage, and provides a high-quality welcome and services to investors, visitors and talent from all over the world, while ensuring the Region's sustainable and balanced development.
BioEconomy Conclave 2026
